Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Accumulated Expenses (2016 - 2024)

Avricore Health has reported Accumulated Expenses over the past 8 years, most recently at $236815.1 for Q4 2024.

  • Quarterly Accumulated Expenses fell 34.1% to $236815.1 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was $236815.1 through Dec 2024, down 34.1% year-over-year, with the annual reading at $241628.5 for FY2024, 33.36% down from the prior year.
  • Accumulated Expenses was $236815.1 for Q4 2024 at Avricore Health, up from $7147.3 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $359348.0 in Q4 2023 and troughed at $4752.4 in Q2 2024.
  • The 4-year median for Accumulated Expenses is $125226.3 (2020), against an average of $143085.9.
  • Year-over-year, Accumulated Expenses soared 55.89% in 2023 and then tumbled 34.1% in 2024.
  • A 4-year view of Accumulated Expenses shows it stood at $19943.4 in 2020, then surged by 1055.82% to $230509.2 in 2022, then soared by 55.89% to $359348.0 in 2023, then plummeted by 34.1% to $236815.1 in 2024.
  • Per Business Quant, the three most recent readings for AVCRF's Accumulated Expenses are $236815.1 (Q4 2024), $7147.3 (Q3 2024), and $4752.4 (Q2 2024).